Similar articles for PMID: 24324064

Year	Number of Results
1978	1
1986	1
1990	2
1993	2
2001	1
2002	1
2003	3
2004	2
2005	4
2006	2
2007	7
2008	6
2009	11
2010	8
2011	5
2012	2
2013	3
2014	3
2015	4
2016	2
2017	2
2018	1
2019	1
2020	2
2021	3
2022	0

1

Prokineticin 1 expression in gastrointestinal tumors.

Goi T, Nakazawa T, Hirono Y, Yamaguchi A. Goi T, et al. Anticancer Res. 2013 Dec;33(12):5311-5. Anticancer Res. 2013. PMID: 24324064

2

Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.

Nakazawa T, Goi T, Hirono Y, Yamaguchi A. Nakazawa T, et al. Ann Surg Oncol. 2015 May;22(5):1496-503. doi: 10.1245/s10434-014-4150-3. Epub 2014 Oct 21. Ann Surg Oncol. 2015. PMID: 25331005

3

The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer.

Goi T, Nakazawa T, Hirono Y, Yamaguchi A. Goi T, et al. Oncotarget. 2015 Mar 20;6(8):6053-61. doi: 10.18632/oncotarget.3474. Oncotarget. 2015. PMID: 25788276 Free PMC article.

4

Anti-prokineticin1 (PROK1) monoclonal antibody suppresses angiogenesis and tumor growth in colorectal cancer.

Goi T, Nakazawa T, Hirono Y, Yamaguchi A. Goi T, et al. Ann Surg Oncol. 2014 Dec;21 Suppl 4:S665-71. doi: 10.1245/s10434-014-3765-8. Epub 2014 May 17. Ann Surg Oncol. 2014. PMID: 24838366

5

Prokineticin-1 evokes secretory and contractile activity in rat small intestine.

Wade PR, Palmer JM, Mabus J, Saunders PR, Prouty S, Chevalier K, Gareau MG, McKenney S, Hornby PJ. Wade PR, et al. Neurogastroenterol Motil. 2010 May;22(5):e152-61. doi: 10.1111/j.1365-2982.2009.01426.x. Epub 2009 Nov 25. Neurogastroenterol Motil. 2010. PMID: 19930539

6

Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines.

Tabata S, Goi T, Nakazawa T, Kimura Y, Katayama K, Yamaguchi A. Tabata S, et al. Oncol Rep. 2013 Feb;29(2):459-63. doi: 10.3892/or.2012.2124. Epub 2012 Nov 6. Oncol Rep. 2013. PMID: 23135359

7

The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).

Goi T, Nakazawa T, Hirono Y, Yamaguchi A. Goi T, et al. Oncotarget. 2015 Oct 6;6(30):28790-9. doi: 10.18632/oncotarget.4744. Oncotarget. 2015. PMID: 26318037 Free PMC article.

8

Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study.

Tagai N, Goi T, Shimada M, Kurebayashi H. Tagai N, et al. World J Surg Oncol. 2021 Oct 18;19(1):302. doi: 10.1186/s12957-021-02421-0. World J Surg Oncol. 2021. PMID: 34657605 Free PMC article.

9

A Common Variant of PROK1 (V67I) Acts as a Genetic Modifier in Early Human Pregnancy through Down-Regulation of Gene Expression.

Su MT, Huang JY, Tsai HL, Chen YC, Kuo PL. Su MT, et al. Int J Mol Sci. 2016 Jan 27;17(2):162. doi: 10.3390/ijms17020162. Int J Mol Sci. 2016. PMID: 26828479 Free PMC article.

10

Prokineticin 1 is up-regulated by insulin in decidualizing human endometrial stromal cells.

Ujvari D, Jakson I, Oldmark C, Attarha S, Alkasalias T, Salamon D, Gidlöf S, Hirschberg AL. Ujvari D, et al. J Cell Mol Med. 2018 Jan;22(1):163-172. doi: 10.1111/jcmm.13305. Epub 2017 Aug 7. J Cell Mol Med. 2018. PMID: 28782224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed